Armata Pharmaceuticals
ARMP----
Armata Pharmaceuticals (ARMP)
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on the development of targeted bacteriophage therapeutics for antib...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Armata Pharmaceuticals Analyst Rating
View MoreForecast & Rating
Jul 20, 2026Price forecast
$17.50275.54%
Forecast & RatingStrong buy
2analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- rttnews · Jul 20 at 10:01 PM
Top Biotech Gainers: ZYBT Skyrockets, ADVB Drops Planned Offering, STIM Gets New CFO, RDGT On Watch
- benzinga_article · Jul 20 at 11:45 AM
Why Is Armata Pharma Stock Gaining Monday?
- MorningStar · Jul 20 at 10:29 AM
Armata Shares Surge on Progress Toward Late-Stage Trial of Superbug Treatment
- Tip Ranks · Jul 20 at 06:28 AM
Armata Advances AP-SA02 Toward Phase 3 Trial Launch
- PUBT · Jul 20 at 06:03 AM
Armata Pharmaceuticals names David House CFO
- prnewswire · Jul 20 at 06:01 AM
07:00 ETArmata Pharmaceuticals Achieves Key Progress Across Clinical, Regulatory and Manufacturing Activities Supporting Planned Phase 3 Initiation of AP-SA02
